Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes

Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes

Abstract Background Mutations in the KEAP1-NFE2L2 signaling pathway were linked to increased tumorigenesis and aggressiveness. Interestingly, not all hotspot mutations on NFE2L2 were damaging; some even were activating. However, there was conflicting evidence about the association between NFE2L2 mut...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Kewei Wang, Zixi Li, Ying Xuan, Yong Zhao, Chao Deng, Meidan Wang, Chenjun Xie, Fenglai Yuan, Qingfeng Pang, Wenjun Mao, Dongyan Cai, Zhangfeng Zhong, Jie Mei
Format:	Artykuł
Język:	English
Wydane:	BMC 2023-10-01
Seria:	Cancer Cell International
Hasła przedmiotowe:	NFE2L2 NSCLC Biomarker NGS Immunotherapy
Dostęp online:	https://doi.org/10.1186/s12935-023-03056-9

Podobne zapisy

Metformin suppresses NFE2L1 pathway activation to inhibit gap junction beta protein expression in NSCLC
od: Shuo Yu, i wsp.
Wydane: (2024-04-01)

Multi-Omics Analysis of Molecular Characteristics and Carcinogenic Effect of NFE2L3 in Pan-Cancer
od: Mengxiao Liu, i wsp.
Wydane: (2022-06-01)

NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases
od: Kamila Łuczyńska, i wsp.
Wydane: (2024-02-01)

Cisplatin Disrupts Proteasome Bounce-Back Effect through Suppressing ZEB1/Nfe2l1 in Cholangiocarcinoma
od: Yuancai Xiang, i wsp.
Wydane: (2024-03-01)

Understanding the Transcription Factor NFE2L1/NRF1 from the Perspective of Hallmarks of Cancer
od: Haomeng Zhang, i wsp.
Wydane: (2024-06-01)

Unravelling the role of NFE2L1 in stress responses and related diseases
od: Xingzhu Liu, i wsp.
Wydane: (2023-09-01)

NFE2L2 and SLC25A39 drive cuproptosis resistance through GSH metabolism
od: Jiao Liu, i wsp.
Wydane: (2024-11-01)

Role of NFE2L1 in the Regulation of Proteostasis: Implications for Aging and Neurodegenerative Diseases
od: Aswathy Chandran, i wsp.
Wydane: (2023-08-01)

Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage
od: Mustafa Elshani, i wsp.
Wydane: (2023-08-01)

A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer
od: Chang Jiang, i wsp.
Wydane: (2022-08-01)

NFE2L3 as a Novel Biomarker Associated With IL-2/STAT5/NLRP3 Signaling Pathway in Malignant Pleural Mesothelioma and Other Cancers
od: Zhen Wang, i wsp.
Wydane: (2022-05-01)

Multi-Omics Analysis of <i>NFE2L2</i>-Altered TCGA-Cervical Squamous Cell Carcinoma Patients
od: Sri Vidya Ramisetti, i wsp.
Wydane: (2023-03-01)

Gallic Acid Improves Diabetic Steatosis by Downregulating MicroRNA-34a-5p through Targeting NFE2L2 Expression in High-Fat Diet-Fed db/db Mice
od: Ang-Tse Lee, i wsp.
Wydane: (2021-12-01)

Prevalence and Associations of Co-occurrence of <i>NFE2L2</i> Mutations and Chromosome 3q26 Amplification in Lung Cancer
od: Jinfeng Liu, i wsp.
Wydane: (2024-06-01)

MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3
od: Yue-chu Dai, i wsp.
Wydane: (2021-12-01)

Impact of Genomic Variation of NFE2L2 (rs6706649) on Serum Glyoxalase-1 Levels in A Sample of Iraqi Type 2 Diabetic Patients with Retinopathy
od: Sarah Hashim Mhaibes, i wsp.
Wydane: (2025-02-01)

New insight into the CNC-bZIP member, NFE2L3, in human diseases
od: Guanghui Xiong, i wsp.
Wydane: (2024-07-01)

Single-nucleus RNA-sequencing reveals NRF1/NFE2L1 as a key factor determining the thermogenesis and cellular heterogeneity and dynamics of brown adipose tissues in mice
od: Wei Shen, i wsp.
Wydane: (2023-11-01)

Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas
od: Xing Jin, i wsp.
Wydane: (2021-12-01)

NFE2/miR-423-5p/TFF1 axis regulates high glucose-induced apoptosis in retinal pigment epithelial cells
od: Qing Xiao, i wsp.
Wydane: (2019-08-01)

Effects of Heat-Induced Oxidative Stress and Astaxanthin on the <i>NF-kB</i>, <i>NFE2L2</i> and <i>PPARα</i> Transcription Factors and Cytoprotective Capacity in the Thymus of Broilers
od: Donna Lee Kuehu, i wsp.
Wydane: (2024-08-01)

Green Tea Polyphenols Alleviate Hydrogen Peroxide-Induced Oxidative Stress, Inflammation, and Apoptosis in Bovine Mammary Epithelial Cells by Activating ERK1/2–NFE2L2–HMOX1 Pathways
od: Yanfen Ma, i wsp.
Wydane: (2022-01-01)

Mutant Nrf2E79Q enhances the promotion and progression of a subset of oncogenic Ras keratinocytes and skin tumors
od: John G. Witherspoon, i wsp.
Wydane: (2024-09-01)

Carnosine Synthase (<i>Ts</i>ATPGD) Alleviates Lipid Peroxidation Under Transcriptional Control by an <i>Nfe2</i>-like Gene in <i>Tridacna Squamosa</i>
od: Zhuo Yang, i wsp.
Wydane: (2024-11-01)

Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report
od: Rui Zhong, i wsp.
Wydane: (2020-02-01)

Retracted: SLCO4A1‐AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR‐4701‐5p/NFE2L1 axis to activate WNT pathway
od: Yuxuan Wei, i wsp.
Wydane: (2020-10-01)

EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
od: Wenfeng Fang, i wsp.
Wydane: (2019-06-01)

PEMBERIAN BEBERAPA DOSIS ENZIM PADA PAKAN KOMERSIAL TERHADAP KANDUNGAN SERAT KASAR, BAHAN ORGANIK DAN BETN
od: Pramono Kusuma Wardani, i wsp.
Wydane: (2019-04-01)

Immunoediting of KEAP1-NRF2 mutant tumours is required to circumvent NRF2-mediated immune surveillance
od: Liam Baird, i wsp.
Wydane: (2023-11-01)

mNFE: microbiome network flow entropy for detecting pre-disease states of type 1 diabetes
od: Rong Gao, i wsp.
Wydane: (2024-12-01)

A NRF2-induced secretory phenotype activates immune surveillance to remove irreparably damaged cells
od: Liam Baird, i wsp.
Wydane: (2023-10-01)

Identification and verification of KEAP1‐related genes and targets regulated by potential ingredients in KRAS mutant colorectal cancer
od: Gang Wang, i wsp.
Wydane: (2024-09-01)

Novel insights into molecular patterns of ROS1 fusions in a large Chinese NSCLC cohort: a multicenter study
od: Shengyu Zhou, i wsp.
Wydane: (2023-10-01)

Individual expression features of GPX2, NQO1 and SQSTM1 transcript variants induced by hydrogen peroxide treatment in HeLa cells
od: Anna A. Belanova, i wsp.
Wydane: (2017-05-01)

Identification and therapeutic evaluation of ALK rearrangements in non‐small‐cell lung cancer
od: Ruiying Zhao, i wsp.
Wydane: (2022-11-01)

Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion
od: Monique G.P. van der Wijst, i wsp.
Wydane: (2015-08-01)

The promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer
od: Mengwen Zhang, i wsp.
Wydane: (2023-07-01)

Maternal Calorie Restriction Induces a Transcriptional Cytoprotective Response in Embryonic Liver Partially Dependent on Nrf2
od: George I. Habeos, i wsp.
Wydane: (2022-11-01)

Next-generation sequencing of non-small cell lung cancer at a Quebec health care cancer centre
od: Mark Sorin, i wsp.
Wydane: (2023-01-01)

Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients
od: Valerio Gristina, i wsp.
Wydane: (2024-09-01)